PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2013Journal of Atherosclerosis and Thrombosis29 citationsOpen Access

Thrombus Aspiration Therapy and Coronary Thrombus Components in Patients with Acute ST-Elevation Myocardial Infarction

KYKei YunokiOkayama UniversityTNTakahiko NarukoKansai Medical UniversityKSKenichi SugiokaOsaka City University

Key Points

  • To review the efficacy of thrombus aspiration therapy and evaluate the relationship between aspirated intracoronary thrombus components, inflammation, oxidative stress, and clinical outcomes in STEMI patients.
  • Reviewed clinical and pathological data regarding thrombus aspiration and distal protection devices during percutaneous coronary intervention in STEMI.

Structured PICO

Does thrombus aspiration therapy improve clinical outcomes and myocardial perfusion in patients with acute ST-elevation myocardial infarction?

P
Population
Patients with acute ST-elevation myocardial infarction (STEMI)
I
Intervention
Thrombus aspiration therapy and distal protection devices
C
Comparator
Standard percutaneous coronary intervention (PCI)

Thrombus aspiration during primary PCI for STEMI improves clinical outcomes, and pathological evaluation of aspirated thrombi reveals that erythrocyte-rich components correlate with worse myocardial reperfusion and increased inflammation.

Limitations

  • Further studies are needed to confirm the association between coronary thrombus components and plaque morphology in patients with acute STEMI

Abstract

Inflammation and oxidative stress play key roles in atherosclerotic plaque instability, and plaque rupture/erosion and subsequent thrombus formation constitute the principal mechanisms of total vessel occlusion and acute ST-elevation myocardial infarction (STEMI). Plaque disruption triggers the formation of initial platelet aggregates that grow in association with an increase in fibrin formation, leading to persistent coronary flow obstruction and blood coagulation. The fibrin network may trap large numbers of erythrocytes and inflammatory cells to form an erythrocyte-rich thrombus. In fact, previous clinical studies have shown that not only platelet-rich white thrombi, but also erythrocyte-rich red thrombi can be visualized using angioscopy in patients with acute coronary syndrome. Recently, the development of thrombus aspiration and distal protection devices has significantly improved the clinical outcomes of percutaneous intervention in STEMI patients and has enabled the evaluation of antemortem coronary artery thrombi. This is important because previous autopsy studies were unable to differentiate coronary thrombi responsible for myocardial ischemia from postmortem clots. Using frozen samples of aspirated thrombi and specific monoclonal antibodies, we investigated the cellular components of thrombi (platelets, erythrocytes, fibrin and inflammatory cells, such as myeloperoxidase-positive cells) and pathologically evaluated the relationships between erythrocyte-rich thrombi and inflammation, oxidative stress and clinical outcomes in STEMI patients. Therefore, this review article focuses on the efficacy of thrombus aspiration therapy and the components of aspirated intracoronary thrombi in STEMI patients and presents the results of recent studies regarding the relationship between the composition of aspirated intracoronary thrombi and clinical outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yunoki et al. (2013) studied this question.

synapsesocial.com/papers/6a1d247f28423f2ce504d221https://doi.org/10.5551/jat.17608
Ask AI
Helpful
Bookmark
Share
View Full Paper